Mycobacterium abscessus D-alanyl-D-alanine dipeptidase induces the maturation of dendritic cells and promotes Th1-biased immunity
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Mycobacterium abscessus, a member of the group of non-tuberculous mycobacteria, has been identified as an emerging pulmonary pathogen in humans. However, little is known about the protective immune response of antigenpresenting cells, such as dendritic cells (DCs), which guard against M. abscessus infection. The M. abscessus gene MAB1843 encodes D-alanyl-D-alanine dipeptidase, which catalyzes the hydrolysis of D-alanyl-D-alanine dipeptide. We investigated whether MAB1843 is able to interact with DCs to enhance the effectiveness of the host’s immune response. MAB1843 was found to induce DC maturation via toll-like receptor 4 and its downstream signaling pathways, such as the mitogen-activated protein kinase and nuclear factor kappa B pathways. In addition, MAB1843-treated DCs stimulated the proliferation of T cells and promoted Th1 polarization. Our results indicate that MAB1843 could potentially regulate the immune response to M. abscessus, making it important in the development of an effective vaccine against this mycobacterium.
Abstract
Mycobacterium abscessus, a member of the group of non-tuberculous mycobacteria, has been identified as an emerging pulmonary pathogen in humans. However, little is known about the protective immune response of antigenpresenting cells, such as dendritic cells (DCs), which guard against M. abscessus infection. The M. abscessus gene MAB1843 encodes D-alanyl-D-alanine dipeptidase, which catalyzes the hydrolysis of D-alanyl-D-alanine dipeptide. We investigated whether MAB1843 is able to interact with DCs to enhance the effectiveness of the host’s immune response. MAB1843 was found to induce DC maturation via toll-like receptor 4 and its downstream signaling pathways, such as the mitogen-activated protein kinase and nuclear factor kappa B pathways. In addition, MAB1843-treated DCs stimulated the proliferation of T cells and promoted Th1 polarization. Our results indicate that MAB1843 could potentially regulate the immune response to M. abscessus, making it important in the development of an effective vaccine against this mycobacterium.
참고문헌 (29)
- Rolston KV, "Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer", Chest, 87, pp.503~506 (1985)
- Set R, "Laboratory aspects of clinically significant rapidly growing mycobacteria", Indian J Med Microbiol, 29, pp.343~352 (2011)
- Jeon K, "Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients", Am J Respir Crit Care Med, 180, pp.896~902 (2009)
- Lee MR, "Mycobacterium abscessus Complex Infections in Humans", Emerg Infect Dis, 21, pp.1638~1646 (2015)
- Maurer FP, "Lack of antimicrobial bactericidal activity in Mycobacterium abscessus", Antimicrob Agents Chemother, 58, pp.3828~3836 (2014)
- Nessar R, "Mycobacterium abscessus: a new antibiotic nightmare", J Antimicrob Chemother, 67, pp.810~818 (2012)
- Shin DM, "Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1", Cell Microbiol, 10, pp.1608~1621 (2008)
- 이수정, "Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune response", BMB Reports, 47(9), pp.512~517 (2014), 생화학분자생물학회
- Sampaio EP, "Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells", Am J Respir Cell Mol Biol, 39, pp.431~439 (2008)
- Haverkamp MH, "Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling", Microbes Infect, 8, pp.1157~1166 (2006)
- Rottman M, "Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL", 6 mice, 2007, pp.75, 5898~5907
- Banchereau J, "Dendritic cells and the control of immunity", Nature, 392, pp.245~252 (1998)
- Banchereau J, "Dendritic cells as therapeutic vaccines against cancer", Nat Rev Immunol, 5, pp.296~306 (2005)
- Palucka K, "Cancer immunotherapy via dendritic cells", Nat Rev Cancer, 12, pp.265~277 (2012)
- Schuler G, "The use of dendritic cells in cancer immunotherapy", Curr Opin Immunol, 15, pp.138~147 (2003)
- Bansal K, "PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells", J Immunol, 184, pp.3495~3504 (2010)
- Pecora ND, "Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function", J Immunol, 177, pp.422~429 (2006)
- Heo DR, "Mycobacterium tuberculosislpdC, Rv0462, induces dendritic cell maturation and Th1 polarization", Biochem Biophys Res Commun, 411, pp.642~647 (2011)
- 이수정, "The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4", BMB Reports, 47(2), pp.115~120 (2014), 생화학분자생물학회
- Jung ID, "Enhanced efficacy of therapeutic cancer vaccines produced by co-treatment with Mycobacterium tuberculosis heparin-binding hemagglutinin, a novel TLR4 agonist", Cancer Res, 71, pp.2858~2870 (2011)
- Jung ID, "Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X", J Immunol, 193, pp.1233~1245 (2014)
- Lee SJ, "A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652enhances dendritic cells-based tumor immunotherapy", PLoS One, 9, pp.e104351~ (2014)
- O'Neill LA, "The history of Toll-like receptors-redefining innate immunity", Nat Rev Immunol, 13, pp.453~460 (2013)
- van Duin D, "Triggering TLR signaling in vaccination", Trends Immunol, 27, pp.49~55 (2006)
- Hogquist KA, "T cell receptor antagonist peptides induce positive selection", Cell, 76, pp.17~27 (1994)
- This official statement of the American Thoracic Society was approved by the Board of Directors, "Diagnosis and treatment of disease caused by nontuberculous mycobacteria", Am J Respir Crit Care Med, 156, pp.S1~S25 (1997)
- Marras TK, "Epidemiology of human pulmonary infection with nontuberculous mycobacteria", Clin Chest Med, 23, pp.553~567 (2002)
- Hayashi F, "The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5", Nature, 410, pp.1099~1103 (2001)
- Lee JS, "D-pinitol inhibits Th1polarization via the suppression of dendritic cells", Int Immunopharmacol, 7, pp.791~804 (2007)
